Health Canada approves Eli Lilly’s GLP-1 pill Foundayo for weight loss. The approval also covers treatment of Type 2 diabetes, according to the reporting.

Outlets describe the medication in terms of how it is taken: City News Toronto emphasizes it is a daily pill rather than weekly injections, highlighting a convenience and dosing-frequency difference. Global News Canada similarly reports on the approval and notes the diabetes indication. Winnipeg Free Press carries the same core information, without additional detail provided in the supplied summary.